Milmed Unico AB
559163-1741ActiveEarly-stage developer of patented medicinal probiotics for chronic diseases.
Biotechnology and Pharmaceutical Development Companymilmedunico.com
Oversikt
- 1–4
- Ansatte
- 100–149t SEK
- Omsetning
- 2018
- Grunnlagt
Beskrivelse
Milmed Unico AB is an early-stage biotechnology company focused on developing groundbreaking medicinal probiotics. Their core technology is based on a patented, non-toxic yeast culture that has shown positive impacts on living cells. The company holds patent protection for treatments targeting three...
Tagger
B2BB2CPharmaceuticalsHealthTechTechnology
IMMUNEBIOTECH MEDICAL NORWAY NUF